After a bitter and divisive re-election campaign, George W. Bush is set to lead the US for the next four years — and that includes directing its science policy. For life science researchers, this means you shouldn’t expect any major flip-flops on issues such as drug reimportation, funding for controversial biological research involving embryos, or major shifts in funding priorities.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.